Brownstone Journal

Brownstone Journal features in-depth articles, news, research, and commentary on public health, science, economics, social theory, and related policy issues — offering critical perspectives on institutional failures, government interventions, and threats to liberty.

Explore topics like vaccine trials, post-pandemic public sentiment, cancer screening dilemmas, weight loss drugs, food systems, digital ID, antidepressants, pandemic profit motives, collapse in public trust, and paths to evidence-based reform, personal freedoms, and a healthier society.

All Brownstone Institute articles are translated into multiple languages to reach global readers, foster international dialogue, and support challenges to centralized narratives worldwide.

Brownstone » Brownstone Journal
The Vaccine Safety Signal the Media Still Won’t Read

The Vaccine Safety Signal the Media Still Won’t Read

SHARE | PRINT | EMAIL

The serious-adverse-event signal found in the Pfizer and Moderna mRNA Covid-19 vaccine trials has been in the peer-reviewed literature for nearly four years. Mainstream media outlets have treated it not as evidence to be weighed but as misinformation to be managed.

The Vaccine Safety Signal the Media Still Won’t Read Continue Reading

The WHO Is Building a Supranational Vaccine Authorization Mechanism

The WHO Is Building a Supranational Vaccine Authorization Mechanism

SHARE | PRINT | EMAIL

The materials point to something more consequential: the use of an international emergency authorization pathway to shape regulatory decisions inside a sovereign state, advanced through overlapping professional networks, without the organization assuming the legal responsibilities borne by national regulators.

The WHO Is Building a Supranational Vaccine Authorization Mechanism Continue Reading

Injected Vaccines, Mucosal Immunity, and Incoherent Estimates of Effectiveness

Injected Vaccines, Mucosal Immunity, and Incoherent Estimates of Effectiveness

SHARE | PRINT | EMAIL

It is time for the FDA to implement a major revision in the approval of the Covid vaccine and the flu vaccine. It is not enough to show effectiveness against symptomatic infection by the test-negative design or by rising antibody titers.

Injected Vaccines, Mucosal Immunity, and Incoherent Estimates of Effectiveness Continue Reading

Join 30,000+ Independent Readers: Get the FREE Brownstone Journal Newsletter